Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations

Home | Back to Search Results

Product Details for NDA 005794

Expand all

SULTRIN (TRIPLE SULFA (SULFABENZAMIDE;SULFACETAMIDE;SULFATHIAZOLE))
3.7%;2.86%;3.42%
Marketing Status: Discontinued

Active Ingredient: TRIPLE SULFA (SULFABENZAMIDE;SULFACETAMIDE;SULFATHIAZOLE)
Proprietary Name: SULTRIN
Dosage Form; Route of Administration: CREAM; VAGINAL
Strength: 3.7%;2.86%;3.42%
Reference Listed Drug: No
Reference Standard: No
TE Code: 
Application Number: N005794
Product Number: 001
Approval Date: Approved Prior to Jan 1, 1982
Applicant Holder Full Name: ORTHO MCNEIL PHARMACEUTICAL INC
Marketing Status:  Discontinued
Patent and Exclusivity Information

SULTRIN (TRIPLE SULFA (SULFABENZAMIDE;SULFACETAMIDE;SULFATHIAZOLE))
184MG;143.75MG;172.5MG
Marketing Status: Discontinued

Active Ingredient: TRIPLE SULFA (SULFABENZAMIDE;SULFACETAMIDE;SULFATHIAZOLE)
Proprietary Name: SULTRIN
Dosage Form; Route of Administration: TABLET; VAGINAL
Strength: 184MG;143.75MG;172.5MG
Reference Listed Drug: No
Reference Standard: No
TE Code: 
Application Number: N005794
Product Number: 002
Approval Date: Approved Prior to Jan 1, 1982
Applicant Holder Full Name: ORTHO MCNEIL PHARMACEUTICAL INC
Marketing Status:  Discontinued
Patent and Exclusivity Information